335 related articles for article (PubMed ID: 28424376)
1.
Lu Z; Wang F; Liang M
Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury.
Wang F; Zhang G; Lu Z; Geurts AM; Usa K; Jacob HJ; Cowley AW; Wang N; Liang M
Kidney Int; 2015 Oct; 88(4):796-803. PubMed ID: 26108065
[TBL] [Abstract][Full Text] [Related]
3. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
Büller HR; ten Cate JW
Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
[TBL] [Abstract][Full Text] [Related]
4. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
6. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J
Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719
[TBL] [Abstract][Full Text] [Related]
7. Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.
Toderici M; de la Morena-Barrio ME; Padilla J; Miñano A; Antón AI; Iniesta JA; Herranz MT; Fernández N; Vicente V; Corral J
PLoS One; 2016; 11(3):e0152159. PubMed ID: 27003919
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
9. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
Rodgers GM
Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III deficiency: clinical relevance and replacement therapy.
Gallus AS
Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
[TBL] [Abstract][Full Text] [Related]
11. c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency.
Kumar R; Dawson JE; Chan AK; Forman-Kay JD; Kahr WH; Williams S
Br J Haematol; 2015 Jul; 170(1):123-5. PubMed ID: 25522812
[No Abstract] [Full Text] [Related]
12. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report.
Wang D; Tian M; Cui G; Wang DW
Front Med; 2018 Jun; 12(3):319-323. PubMed ID: 28861852
[TBL] [Abstract][Full Text] [Related]
14. Seventeen novel SERPINC1 variants causing hereditary antithrombin deficiency in a Czech population.
Provazníková D; Matýšková M; Čápová I; Grančarová D; Drbohlavová E; Šlechtová M; Hrachovinová I
Thromb Res; 2020 May; 189():39-41. PubMed ID: 32151802
[No Abstract] [Full Text] [Related]
15. Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6.
de la Morena-Barrio B; de la Morena-Barrio ME; Padilla J; Teruel-Montoya R; Asenjo S; Wypasek E; Undas A; Miñano A; Vicente V; Corral J
Thromb Haemost; 2018 May; 118(5):939-941. PubMed ID: 29564838
[No Abstract] [Full Text] [Related]
16. Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency.
Wang TF; Dawson JE; Forman-Kay JD; Kahr WHA; Williams S; Chan AK; Kumar R
Br J Haematol; 2017 May; 177(4):654-656. PubMed ID: 27098850
[No Abstract] [Full Text] [Related]
17. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients.
Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H
Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013
[TBL] [Abstract][Full Text] [Related]
18. SERPINC1 gene mutations in antithrombin deficiency.
Mulder R; Croles FN; Mulder AB; Huntington JA; Meijer K; Lukens MV
Br J Haematol; 2017 Jul; 178(2):279-285. PubMed ID: 28317092
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.
Tamura S; Hashimoto E; Suzuki N; Kakihara M; Odaira K; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Suzuki A; Okamoto S; Kanematsu T; Matsushita T; Kojima T
Thromb Res; 2019 Jun; 178():159-170. PubMed ID: 31030036
[TBL] [Abstract][Full Text] [Related]
20. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
